BY- DR.S.KAMESHWARAN
ANTI
ANXIETY
DRUGS
ANXIETY:
“It is an emotional state, unpleasant in nature,
associated with uneasiness, discomfort and
fear about some defined or undefined future
threat”
In normal life some degree of anxiety is
common
But treatment needs when it increases
ANTI ANXIETY DRUGS:
“They are mild CNS depressants, control the
symptom of anxiety and produce a rest full
state of mind, without interfering normal
mental / physical function.”
Anti anxiety drugs more closely resembles
sedative hypnotics
Do not produce extra pyramidal side effects
Have anticonvulsant property
Produce physical dependence & carry
abuse liability.
ANTI ANXIETY DRUGS CLASSIFICATION
 BENZODIAZEPINES
CHLORDIAZEPOXIDE
DIAZEPAM
OXAZEPAM
 AZAPIRONES
BUSPIRONE
GEPIRONE
ISPAPIRONE
 SEDATIVE ANTIHISTAMINIC
HYDROXYZINE
 BETA BIOCKER
PROPRANOLOL
BENZODIAZEPINES (BZD):
Commonly used anti anxiety drug,
Some BZDs have slow and prolonged activity
Relieve anxiety at low dose without producing
CNS depression
it also have hypnotic, muscle relaxant,
anticonvulsant activity
Less toxic and low addiction liability,
Better quality and quantity of improvement in
anxiety and stress than the barbiturates
At anxiety dose it produces minor
cardiovascular and respiratory depression.
Eg: CHLORDIAZEPOXIDE
It was the first BZD to be used clinically
Produce smooth long lasting effect
Preferred in chronic anxiety status
Often combined with other drugs
Has poor anti convulsant action.
MECHANISM OF ACTION:
BENZODIAZEPINES
↓
BINDS TO BZD RECEPTOR PRESENT IN THE Α SUB UNIT
OF GABA-A RECEPTOR
↓
IT INCREASE THE BINDING OF GABA TO THE GABA-A
RECEPTOR
↓
INCREASES THE INFLUX OF MORE Cl- IONS IN TO
INTRACELLULAR SITE
↓
HYPERPOLARIZATION
↓There by it produce
CALMING EFFECT
↓
ANTI ANXIETY ACTIVITY
PHARMACOKINETICS:
Oral absorption slow
T1/2 5 to 15 hours
ADR:
Dizziness
Vertigo
Ataxia
Disorientation
Amnesia
Dizziness
Dizziness
Vertigo
Ataxia
AZAPIRONES
Eg: Buspirone
It is the First Azapirone
Newer anti anxiety drug
It relieves mild to moderate generalized anxiety
It is ineffective at severe cases
Dose not interact with BZD receptors
Doesn’t produce tolerance or physical
dependence
It does not have sedative, hypnotic muscle
relaxant activity like BZD
MECHANISM OF ACTION:
• Not clearly known
• Anti anxiety activity might be due to
Agonist activity on 5 HT1A receptors
Weak dopamine D2 blocking action
PHARMACOKINETICS:
Rapidly absorbed orally
Effect develops slowly
Maximum benefits may be delayed up to 2 weeks
Extensive first pass metabolism
Excreated in both urine and feaces
ADR:
Dizziness
Nausea
Headache
Excitement
BETA BIOCKER:
Many symptoms of anxiety like
palpitation,
rise in BP,
shaking,
tremor,
gastro intestinal hurrying
- occurs due to sympathetic over activity
The beta blockers produce symptomatic relief from
the anxiety
But they do not affect psychological symptoms
They may be used as adjuvant along with BZD
THANK U

ANTI ANXIETY AGENTS / DRUGS USED IN THE TREATMENT OF ANXIETY

  • 1.
  • 2.
    ANXIETY: “It is anemotional state, unpleasant in nature, associated with uneasiness, discomfort and fear about some defined or undefined future threat” In normal life some degree of anxiety is common But treatment needs when it increases
  • 3.
    ANTI ANXIETY DRUGS: “Theyare mild CNS depressants, control the symptom of anxiety and produce a rest full state of mind, without interfering normal mental / physical function.” Anti anxiety drugs more closely resembles sedative hypnotics Do not produce extra pyramidal side effects Have anticonvulsant property Produce physical dependence & carry abuse liability.
  • 4.
    ANTI ANXIETY DRUGSCLASSIFICATION  BENZODIAZEPINES CHLORDIAZEPOXIDE DIAZEPAM OXAZEPAM  AZAPIRONES BUSPIRONE GEPIRONE ISPAPIRONE  SEDATIVE ANTIHISTAMINIC HYDROXYZINE  BETA BIOCKER PROPRANOLOL
  • 5.
    BENZODIAZEPINES (BZD): Commonly usedanti anxiety drug, Some BZDs have slow and prolonged activity Relieve anxiety at low dose without producing CNS depression it also have hypnotic, muscle relaxant, anticonvulsant activity Less toxic and low addiction liability, Better quality and quantity of improvement in anxiety and stress than the barbiturates At anxiety dose it produces minor cardiovascular and respiratory depression.
  • 6.
    Eg: CHLORDIAZEPOXIDE It wasthe first BZD to be used clinically Produce smooth long lasting effect Preferred in chronic anxiety status Often combined with other drugs Has poor anti convulsant action.
  • 7.
    MECHANISM OF ACTION: BENZODIAZEPINES ↓ BINDSTO BZD RECEPTOR PRESENT IN THE Α SUB UNIT OF GABA-A RECEPTOR ↓ IT INCREASE THE BINDING OF GABA TO THE GABA-A RECEPTOR ↓ INCREASES THE INFLUX OF MORE Cl- IONS IN TO INTRACELLULAR SITE ↓ HYPERPOLARIZATION ↓There by it produce CALMING EFFECT ↓ ANTI ANXIETY ACTIVITY
  • 9.
    PHARMACOKINETICS: Oral absorption slow T1/25 to 15 hours ADR: Dizziness Vertigo Ataxia Disorientation Amnesia
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
    AZAPIRONES Eg: Buspirone It isthe First Azapirone Newer anti anxiety drug It relieves mild to moderate generalized anxiety It is ineffective at severe cases Dose not interact with BZD receptors Doesn’t produce tolerance or physical dependence It does not have sedative, hypnotic muscle relaxant activity like BZD
  • 15.
    MECHANISM OF ACTION: •Not clearly known • Anti anxiety activity might be due to Agonist activity on 5 HT1A receptors Weak dopamine D2 blocking action
  • 16.
    PHARMACOKINETICS: Rapidly absorbed orally Effectdevelops slowly Maximum benefits may be delayed up to 2 weeks Extensive first pass metabolism Excreated in both urine and feaces ADR: Dizziness Nausea Headache Excitement
  • 17.
    BETA BIOCKER: Many symptomsof anxiety like palpitation, rise in BP, shaking, tremor, gastro intestinal hurrying - occurs due to sympathetic over activity The beta blockers produce symptomatic relief from the anxiety But they do not affect psychological symptoms They may be used as adjuvant along with BZD
  • 18.